Search NASA⌕ Search

SEARCH · Search NASA

Results for “SYNCHROCYCLOTRONS”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 records

New laser setup for the selective isotope production and investigation in a laser ion source at the IRIS (Investigation of Radioactive Isotopes on Synchrocyclotron) facility

New laser installation for the resonance ionization spectroscopy in a laser ion source and for rare isotope production has been recently put into operation at the IRIS (Investigation of Radioactive Isotopes on Synchrocyclotron) facility (Petersburg Nuclear Physics Institute, Gatchina). This is a significant improvement of a previous target-laser ion source device of the IRIS mass-separator, working on-line with 1 GeV proton beam of PNPI (Petersburg Nuclear Physics Institute) synchrocyclotron. It makes possible for us to get the isobarically clean radioactive isotope beams of a great number of chemical elements. New laser setup provides the two- or three-resonance step ionization in the range of wavelength of 265-850 nm. The first results obtained at the laser setup for Tl isotopes are presented.

07 ISOTOPE AND RADIATION SOURCES↗

Brief overview of the creation of the synchrocyclotron at the hydrotechnical laboratory of the USSR Academy of Sciences and first results of physical studies: Review of archival documents

A review of the archive’s documents on the main stages of the creation of the synchrocyclotron at the Hydrotechnical Laboratory (now known as the Dzhelepov Laboratory of Nuclear Problems) is presented. The review is based on minutes of the Special Committee and Scientific and Technical Council (NTS), which belongs to the First Chief Directorate (PGU) concerning the era of the Soviet atomic project (1945–1953). The analysis of these minutes has enabled us to prepare a chronicle of events that deal with the creation of the synchrocyclotron, as well as the discussion of the project and its place of construction, the research and development program, and so on. The minutes of two NTS meetings dated May 5 and 12, 1952 are devoted to discussing the results the research and development program in 1950–1951. The minutes of NTS meetings have not been published previously.

43 PARTICLE ACCELERATORS↗

Particle acceleration in a variable-energy synchrocyclotron by a single-tuned variable-frequency drive

Ions are released over time from an ion source into a beam area proximate a central axis. A radiofrequency (RF) system with a variable frequency and variable voltage accelerates the ions in orbiting trajectories expanding outward from the central axis. The ions are accelerated to different extraction energy levels within a given design range at a shared extraction radius from the central axis. An RF-frequency versus ion-time-of-flight scenario is set such that the frequency versus time scenario is the same for any ion extraction energy from the given design range, and a constant-or-variable-RF-voltage versus ion-time-of-flight scenario is adjusted to provide ion acceleration from injection to extraction for ions with different respective extraction energy levels within the given design range; and the ions are extracted at the different energy levels at the shared extraction radius.

Radovinsky, Alexey↗

First multi-institutional systematic comparison of the neutron ambient dose equivalent produced by proton therapy systems

Objective. Isochronous cyclotrons, synchrocyclotrons, and synchrotrons are used to accelerate protons for proton therapy. An accurate measurement of neutron doses generated by these accelerators and associated delivery systems and its clinical relevance requires systematic protocols and proper neutron dosimetry for a meaningful assessment. We present the first comprehensive comparison of neutron ambient dose equivalent (H*(10)) produced by clinically operational proton therapy systems. Approach. Treatment plans with 10 cm modulation-depth and ranges of 10 cm (R10M10) and 25 cm (R25M10) were created to cover a 10 × 10 × 10 cm 3 water target. The pencil beam scanning proton therapy machines studied were: two gantry-mounted synchrocyclotrons (Hyperscan, Mevion, half-gantry), two isochronous cyclotrons (ProBeam, Varian, full-gantry), one isochronous cyclotron (Proteus, IBA, full-gantry), and two synchrotrons (PROBEAT, Hitachi, full- and half-gantry). Proton beams were delivered to 30 × 30 × 40 cm 3 plastic water phantoms. WENDI-II and LUPIN-BF3-NP neutron rem-meters were positioned at three angles (0°, 45°, 90°) relative to the beam direction to measure the neutron H*(10) at distances between 50–300 cm from the isocenter. Main results. H*(10) showed dependence on beam energy, machine type, and measurement location. The highest reading was for the gantry-mounted synchrocyclotron, whereas other systems produced approximately comparable neutron doses. In all cases, the H*(10) reduced with distance from the isocenter. The H*(10) drop at 2 m distance compared to that at 0.5 m was a factor of ∼5 for the gantry-mounted synchrocyclotron whereas in other systems the decrease was a factor of 10. The WENDI-II device suffered from dead-time-associated under-estimation of the dose by a factor of ∼2–3 under the synchrocyclotron beam due to its high dose-per-pulse. However, WENDI-II and LUPIN-BF3-NP results were within reasonable agreement in isochronous cyclotron and synchrotron beams, indicating that both devices are suitable for those systems. Significance. Neutron H*(10) is dependent on various parameters including beam energy, measurement location, as well as machine design. Caution must be exercised in choosing the appropriate neutron-dose-measurement device to be used for low-duty-factor, particularly in high-instantaneous-rate proton delivery systems. By delivering the same volumetric proton dose across different machines, this work provides a benchmark for inter-system comparisons and serves as a foundation for future studies.

LUPIN↗

TH-CD-201-10: Highly Efficient Synchronized High-Speed Scintillation Camera System for Measuring Proton Range, SOBP and Dose Distributions in a 2D-Plane

Purpose: Proton therapy (PT) delivery is complex and extremely dynamic. Therefore, quality assurance testing is vital, but highly time-consuming. We have developed a High-Speed Scintillation-Camera-System (HS-SCS) for simultaneously measuring multiple beam characteristics. Methods: High-speed camera was placed in a light-tight housing and dual-layer neutron shield. HS-SCS is synchronized with a synchrocyclotron to capture individual proton-beam-pulses (PBPs) at ∼504 frames/sec. The PBPs from synchrocyclotron trigger the HS-SCS to open its shutter for programmed exposure-time. Light emissions within 30×30×5cm3 plastic-scintillator (BC-408) were captured by a CCD-camera as individual images revealing dose-deposition in a 2D-plane with a resolution of 0.7mm for range and SOBP measurements and 1.67mm for profiles. The CCD response as well as signal to noise ratio (SNR) was characterized for varying exposure times, gains for different light intensities using a TV-Optoliner system. Software tools were developed to analyze ∼5000 images to extract different beam parameters. Quenching correction-factors were established by comparing scintillation Bragg-Peaks with water scanned ionization-chamber measurements. Quenching corrected Bragg-peaks were integrated to ascertain proton-beam range (PBR), width of Spared-Out-Bragg-Peak (MOD) and distal.

07 ISOTOPE AND RADIATION SOURCES↗

Compact, Low-Cost, Light-Weight, Superconducting, Ironless Cyclotrons for Hadron Radiotherapy (Final Report)

This is the final report of a conceptual design study to demonstrate the feasibility of an ironless, superconducting synchrocyclotron for use as a particle accelerator in the clinical treatment of cancer using proton beam radiotherapy (PBRT). Furthermore, the ironless synchrocyclotron approach can be scaled up to accelerate light ions up to carbon, offering significant treatment advantages over conventional proton therapies, and offers a path for more rapid introduction of this technology to clinical uses.

43 PARTICLE ACCELERATORS↗

Compact, Low-Cost, Light-Weight, Superconducting, Ironless Cyclotrons for Hadron Radiotherapy

Superconducting cyclotrons are increasingly employed for proton beam radiotherapy treatment (PBRT). The use of superconductivity in a cyclotron design can reduce its mass by an order of magnitude and size by a factor of 3-4 over conventional resistive magnet technology, yielding significant reduction in overall cost of the device, the accelerator vault, and its infrastructure, as well as reduced operating costs. At MIT, previous work was focused on developing a very high field (9 T at the pole face) superconducting synchrocyclotron that resulted in a highly compact device that is about an order of magnitude lighter, and much smaller in diameter than a conventional, resistive cyclotron. The results of the study reported here were focused on a conceptual design for a compact superconducting synchrocyclotron to demonstrate the possibility to further reduce its weight by almost another order of magnitude by eliminating all iron from the device. In the absence of magnetic iron poles, the magnetic field profile in the beam gap is achieved through a set of main superconducting split pair coils energized in series with a set of distributed field-shaping superconducting coils. External magnetic field shielding is achieved through a set of outer, superconducting ring coils, also connected in series with the other coils, to cancel the stray magnetic field. These shielding coils replace the heavy iron yoke which is the conventional method to return the magnetic flux. It is noted that the 10 Gauss surface is located at a radius of about 3.5 m comparable in both ironless and conventional devices, even in the absence of iron in the ironless device. An important result from eliminating all magnetic iron in the flux circuit is the resulting linear relationship between the operating current and the magnetic field intensity. In the case with iron, the saturation of the magnetic field forces operation at one value of magnetic field. This feature design then enables continuous beam energy variation without the use of an energy degrader, thus eliminating secondary radiation during the in-depth beam scanning, increasing the ion current delivered to the patient and improving the beam quality. The beam energy is determined by the magnetic field strength at the extraction radius, and changing the field enables selection of the final beam energy. The magnetic field can be adjusted while maintaining the needed radial field profile.

Minervini, Joseph V.↗

Space Radiation Effects Laboratory

The SREL User's Handbook is designed to provide information needed by those who plan experiments involving the accelerators at this laboratory. Thus the Handbook will contain information on the properties of the machines, the beam parameters, the facilities and services provided for experimenters, etc. This information will be brought up to date as new equipment is added and modifications accomplished. This Handbook is influenced by the many excellent models prepared at other accelerator laboratories. In particular, the CERN Synchrocyclotron User's Handbook (November 1967) is closely followed in some sections, since the SREL Synchrocyclotron is a duplicate of the CERN machine. We wish to thank Dr. E. G. Michaelis for permission to draw so heavily on his work, particularly in Section II of this Handbook. We hope that the Handbook will prove useful, and will welcome suggestions and criticism.

Source record↗

Proton Therapy At Siteman Cancer Center: The State Of The Art

Barnes-Jewish Hospital is on the verge of offering proton radiation therapy to its patients. Those treatments will be delivered from the first Monarch 250, a state-of-the-art cyclotron produced by Still River Systems, Inc., Littleton, MA. The accelerator is the world's first superconducting synchrocyclotron, with a field-strength of 10 tesla, providing the smallest accelerator for high-energy protons currently available. On May 14, 2010 it was announced that the first production unit had successfully extracted 250 MeV protons. That unit is scheduled for delivery to the Siteman Cancer Center, an NCI-designated Comprehensive Cancer Center at Washington University School of Medicine. At a weight of 20 tons and with a diameter of less than 2 meters the compact cyclotron will be mounted on a gantry, another first for proton therapy systems. The single-energy system includes 3 contoured scatterers and 14 different range modulators to provide 24 distinct beam delivery configurations. This allows proton fields up to 25 cm in diameter, with a maximum range from 5.5 to 32 cm and spread-out-Bragg-peak extent up to 20 cm. Monte Carlo simulations have been run using MCNPX to simulate the clinical beam properties. Those calculations have been used to commission a commercial treatment planning system prior to final clinical measurements. MCNPX was also used to calculate the neutron background generated by protons in the scattering system and patient. Additional details of the facility and current status will be presented.

43 PARTICLE ACCELERATORS↗

Startup of the Kling Center for Proton Therapy

In November of 2011 Mevion Medical Systems (formerly Still River Systems) delivered the Mevion S250 proton therapy system accelerator to the Kling Center for Proton Therapy at the Siteman Cancer Center in Saint Louis. The Mevion system is unique, with an in-room gantry-mounted superconducting synchrocyclotron. This is the first true single-room proton therapy system and it has a greatly reduced size as well as cost. A month after its arrival, the installation was complete and the superconducting magnet was ramped up to full current ({approx}2000 amperes). In March of 2012, full energy beam (250 MeV) was extracted and radiation surveys were performed to verify the shielding. Once that was shown to be sufficient, Mevion began fine-tuning the system to provide a highly isocentric beam from the 50 ton system. In June of 2012 the field-shaping system (energy degraders, contoured scatterers and range modulators) were installed and measurements of the clinical beam properties commenced. Monte Carlo simulations (MCNPX) have been performed for the system and validated with beam measurements done at the factory. These simulations have been used for a preliminary commissioning of our treatment planning system. Additionally, predictions of the neutron background have been made and validated with factory measurements. Final commissioning of the treatment planning system and verification of the neutron background will be accomplished with measurements made later in 2012. Based on current progress, patient treatments are scheduled to begin in late 2012. Beam and radiation background data will be presented.

43 PARTICLE ACCELERATORS↗